MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema

NCT04187443 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Macular Edema
Macular Edema
Type 2 Diabetes With Diabetic Macular Edema
Type 1 Diabetes With Diabetic Macular Edema
Diabetic Retinopathy

Interventions

DRUG: MS-553

Sponsor

Shenzhen MingSight Relin Pharmaceuticals Co., Ltd.

Collaborators

[object Object]